Stem cell therapy for dilated cardiomyopathy
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Stem Cell Therapy for Dilated Cardiomyopathy." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437567/all/Stem_cell_therapy_for_dilated_cardiomyopathy.
Stem cell therapy for dilated cardiomyopathy. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437567/all/Stem_cell_therapy_for_dilated_cardiomyopathy. Accessed November 25, 2024.
Stem cell therapy for dilated cardiomyopathy. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437567/all/Stem_cell_therapy_for_dilated_cardiomyopathy
Stem Cell Therapy for Dilated Cardiomyopathy [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437567/all/Stem_cell_therapy_for_dilated_cardiomyopathy.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Stem cell therapy for dilated cardiomyopathy
ID - 437567
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437567/all/Stem_cell_therapy_for_dilated_cardiomyopathy
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -